You are here : Home > Scientific news > Protein kinase CK2, a theranostic biomarker

Highlight | Biomarkers

Protein kinase CK2, a theranostic biomarker


​​​​​​​
By having the properties of a marker in several types of cancer and the qualifications of a therapeutic target, researchers at the Cancer Biology and Infection laboratory demonstrate that protein kinase CK2 has acquired the status of a relevant theranostics biomarker.​​​

Published on 2 March 2011

 ​​

Top page